# Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance), Division 7: Mixed marketing authorisation applications

Extent: E+W+S+N.I.

Mixed marketing authorisation applications are applications where Part(s) 3 and/or 4 of the dossier consist of safety and efficacy studies carried out by the applicant as well as bibliographical references. All other part(s) are in accordance with the structure described in Part 1 of Title I of this Annex. The competent authority shall accept the proposed format presented by the applicant on a case-by-case basis.

---
Source: https://www.legislation.gov.uk/eur/2019/6/annex/II/title/III/division/7 (the official version)
Page: https://openlegislation.uk/eu-regulation-2019-6/annex-II/title-III/division-7
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.